59 filings
8-K
ZNTL
Zentalis Pharmaceuticals Inc
11 Apr 24
Departure of Directors or Certain Officers
7:00am
8-K
ZNTL
Zentalis Pharmaceuticals Inc
9 Apr 24
Regulation FD Disclosure
4:30pm
8-K
ZNTL
Zentalis Pharmaceuticals Inc
27 Feb 24
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
7:04am
8-K
ZNTL
Zentalis Pharmaceuticals Inc
15 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:12pm
8-K
ZNTL
Zentalis Pharmaceuticals Inc
25 Jan 24
Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments
7:03am
8-K
v784l
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
f9k08m354f7vdcuz
6 Nov 23
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
9:04am
8-K
jbouh
6 Oct 23
Departure of Directors or Certain Officers
5:00pm
8-K
figewz 2wcg1s
13 Sep 23
Regulation FD Disclosure
7:00am
8-K
fz57rc112
9 Aug 23
Regulation FD Disclosure
4:15pm
8-K
o0r7ox4dejyux9seelyg
9 Aug 23
Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
7:03am
8-K
e6mqwstucv3vmg
16 Jun 23
Amendments to Articles of Incorporation or Bylaws
5:19pm
8-K
0g71j03j
15 Jun 23
Other Events
4:23pm
8-K
l4yiark82408eiogtf7
15 Jun 23
Other Events
6:02am
8-K
pzs5x
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
8-K
yr7un 4f814g556nm6rh
5 Jun 23
Regulation FD Disclosure
2:24pm
8-K
yeixdsfja2en2ks
26 May 23
Regulation FD Disclosure
12:38pm
8-K
j6i351t7i6f8w
10 May 23
Zentalis Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
7:04am
8-K
vffmhzamrm agzgrvy9u
26 Apr 23
Regulation FD Disclosure
5:00pm
8-K
g01ex7zr
17 Apr 23
Zentalis announces preclinical data supporting Cyclin E1 as a predictive marker for azenosertib treatment at AACR Annual Meeting 2023
9:07am